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Introduction
Advanced glycation end products (AGEs) are non-enzymatic, glycated products of proteins, lipids and DNA. Production of AGEs is greatly accelerated in diabetes and this has been recognized as one of the main factors associated with endothelial dysfunction and diabetes complications. 1 -4 Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases able to degrade extracellular matrix (ECM), the levels of which are closely related to ECM turnover.
MMP-2, a gelatinase predominantly secreted by endothelial cells, is involved in the degradation of type IV collagen, the main component of subendothelial basement membrane. 5 The integrity of the basement membrane is very important in maintaining endothelial function. It has been reported that AGEs L Gao, L Kang, Q Chen et al.
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influence the production and activity of MMP-2 in various cells, 3, 6 but their effects on MMP-2 in vascular endothelial cells have not been examined. This study investigated the effects of AGEs on the production and activity of MMP-2, and on the receptor for AGEs (RAGE), in human umbilical vein endothelial cells in order to explore a mechanism through which AGEs may promote endothelial dysfunction.
Materials and methods

SYNTHESIS OF AGES
The AGEs were synthesized under sterile conditions by incubating 20 mg/ml low endotoxin bovine serum albumin (BSA) (Merck, San Diego, CA, USA) with 50 mmol/l glucose for 90 days as previously reported, 1 and then fully dialysing against phosphatebuffered saline to remove unbound glucose. As a negative control of AGEs, BSA was incubated without glucose under the same conditions.
CELL CULTURE
Primary human umbilical vein endothelial cells (HUVECs) were cultured to 80% confluence (three to four passages) as described previously. 1 They were exposed to: various concentrations of AGEs (0, 0.05, 0.1, 0.2 or 0.4 mg/ml) or to the negative control at a concentration of 0.4 mg/ml for 24 h (control); and to 0.2 mg/ml AGEs for 0, 6, 12, 18 or 24 h or to 0 mg/ml AGEs for 24 h (24 h control). Conditioned serum-free medium from each of the incubated samples was collected for gelatin zymography.
WESTERN BLOT
The levels of MMP-2 and RAGE protein in the HUVECs were analysed by Western blot using rabbit anti-human MMP-2 (1:400, Chemicon, Billerica, MA, USA) and mouse anti-human RAGE antibody (1:1500, Chemicon) as previously described. 7 
REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION
ZYMOGRAPHY
Gelatin zymography was used to measure the activity of MMP-2 in the conditioned medium, as previously reported. 8 Medium of SMMC-7721, a hepatoma carcinoma cell line, was used as the positive control. The area digested by MMP-2 was quantified with Image J version 1.34 (National Institutes of Health, Bethesda, MD, USA).
STATISTICAL ANALYSIS
All results were expressed as the mean ± SD. Data were analysed using analysis of variance and subjected to post hoc comparisons using Dunnett's test (SPSS ® statistical software, SPSS Inc., Chicago, IL, USA). A P-value < 0.05 (two-tailed) was considered to be statistically significant.
Results
EFFECTS ON MMP-2 AND RAGE PROTEIN AND GENE EXPRESSION
The effects of AGEs on MMP-2 and RAGE L Gao, L Kang, Q Chen et al. AGEs and MMP-2 in human umbilical vein endothelial cells (Figs 1 and 2) . Incubation with AGEs at concentrations of ≥ 0.2 mg/ml for 24 h significantly inhibited MMP-2 expression but significantly increased RAGE expression compared with controls. Incubation with 0.2 mg/ml AGEs for ≥ 18 h significantly inhibited MMP-2 but significantly increased RAGE expression compared with controls.
EFFECTS ON MMP-2 ACTIVITY IN CONDITIONED MEDIUM
The effects of AGEs on MMP-2 activity in the conditioned medium were also time and concentration dependent (Fig. 3) . Both latent and active MMP-2 were found, with latent MMP-2 being the main form in HUVECs.
Discussion
An increasing number of clinical trials suggest that patients with diabetes suffer more serious coronary and peripheral artery disease and have increased morbidity and mortality. 9 The serum concentration of AGEs is almost 10 times higher in diabetic patients than in non-diabetic subjects. 1 There is growing evidence supporting the involvement of AGEs and MMPs in atherosclerosis, retinopathy, nephropathy and other diabetic complications. 1 -4,6 It has been reported that AGEs influence the expression and activity of MMPs in cells such as macrophages and choroidal endothelial cells; 3,6 however, the effects of AGEs on MMP expression and activity in vascular endothelial cells has not been investigated.
In the present study, AGEs increased RAGE protein and gene expression but decreased MMP-2 protein and gene expression in HUVECs, and inhibited MMP-2 activity in conditioned medium in a time-and concentration-dependent manner. Since RAGE is a signal transduction receptor for AGEs on the cell surface, 10 these results suggest that the effects of AGEs on MMP-2 may be mediated through RAGE. As the serum concentration of AGEs is approximately 0.2 mg/ml in diabetic patients, 1 the changes seen in this study may occur in diabetes.
Matrix metalloproteinases are very important in maintaining ECM homeostasis and participate in many physiological and pathological processes. Disturbed ECM remodelling is involved in the pathogenesis of atherosclerosis and other vascular disorders. 11 -13 Decreased secretion and activity of MMP-2 in endothelial cells may disturb the turnover of subendothelial ECM, 5 resulting in accumulation of abnormal matrix, thickening and hardening of the basement membrane and endothelial dysfunction, thus influencing angiogenesis or contributing to vascular complications. The present results suggest that AGEs may alter endothelial function by decreasing MMP-2 expression and activity in endothelial cells. The effects of AGEs on MMPs in the endothelium of diabetic patients need further study.
